The 2026 Nobel Prize in Physiology or Medicine has highlighted a scientific breakthrough that transformed the study of the brain—and an Indian scientist's early research formed part of the chain of discoveries that made that breakthrough possible.
Professor Suneel Kateriya, now associated with Jawaharlal Nehru University (JNU), was working as a doctoral researcher in Peter Hegemann's laboratory in Germany when he identified genes associated with light-sensitive proteins in the single-celled alga Chlamydomonas in 2001. The work later became connected to the development of optogenetics, a technique that allows scientists to control selected nerve cells using light.
The 2026 Nobel Prize was awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries leading to optogenetics and the use of light-gated ion channels to control the activity of nerve cells.
How an alga helped transform neuroscience
The research began with a basic biological question: how does a microscopic alga detect and respond to light?
K. Chlamydomonas uses a light-sensing structure to orient itself toward light. During his work in Germany, Kateriya identified DNA sequences associated with two previously characterised light-sensitive proteins. The genes were subsequently known as channelrhodopsin-1 and channelrhodopsin-2.
At the time, the research was focused on understanding how the organism sensed its environment. Its eventual importance to neuroscience was not immediately apparent.
Subsequent experiments showed that channelrhodopsins function as light-gated ion channels. When exposed to light, they can alter the electrical state of cells.
From basic biology to a tool for controlling neurons
The crucial development came when researchers adapted these light-sensitive proteins for use in nerve cells.
By introducing the relevant genes into neurons, scientists could make selected cells responsive to light. This provided a level of control that earlier techniques struggled to achieve.
Traditional methods such as electrical stimulation can affect groups of nearby neurons and fibres, while chemical approaches may act more broadly and for longer periods. Optogenetics offered researchers the ability to target particular cell populations and influence their activity with extremely high temporal precision.
Research by Deisseroth and other scientists subsequently demonstrated that light could be used to activate neurons carrying these proteins, establishing optogenetics as a powerful neuroscience technique.
What exactly is optogenetics?
Optogenetics combines genetics and light-based stimulation.
Scientists can introduce genes that produce light-sensitive proteins into specific types of cells. Once those proteins are present, appropriately delivered light can alter the electrical activity of the targeted cells.
In neuroscience, this makes it possible to investigate cause and effect: researchers can activate or inhibit a particular group of neurons and observe what changes in an animal's behaviour or physiology.
That precision has made optogenetics an important research method for investigating neural circuits involved in areas such as memory, behaviour and neurological disease.
The technology has already changed brain research
One important application involved studying the relationship between specific neurons and memory.
Researchers have used optogenetic techniques in animals to identify neural populations associated with particular experiences and then manipulate their activity. Such experiments helped scientists investigate whether particular groups of cells were causally involved in behavioural responses.
The significance is not that optogenetics can simply “control the human brain”. Rather, the technology gives researchers an experimental tool for studying individual neural circuits with a precision that was previously difficult to achieve.
Early clinical applications are emerging
The technology has also moved beyond laboratory neuroscience into experimental medical research.
One notable area is vision restoration. Researchers have investigated whether light-sensitive proteins can make surviving retinal cells responsive to light in people with certain forms of blindness.
A 2021 clinical study reported that a patient with retinitis pigmentosa achieved limited visual functions using an optogenetic approach combined with specialised goggles. The result represented partial visual recovery rather than restoration of normal sight.
These developments demonstrate the potential of the technology, but many possible medical applications remain experimental. Optogenetic treatments for conditions such as epilepsy or depression are not established clinical therapies today.
Kateriya’s contribution to the scientific journey
Kateriya's role lies in the early molecular work that helped identify the genetic basis of channelrhodopsins.
The Nobel-winning research is therefore the result of a much longer scientific progression rather than a single experiment. The discovery of light-sensitive proteins in algae provided an important biological foundation; later research established their function and eventually adapted them into tools for manipulating neural activity.
Kateriya has also emphasised the collaborative nature of the work, describing his contribution as one part of a broader scientific effort led by researchers including his doctoral supervisor Peter Hegemann.
Why the Nobel recognition matters for India
The connection is significant for Indian science because Kateriya's early contribution links an Indian researcher to one of the most influential developments in modern neuroscience.
It also illustrates how fundamental research can produce applications far removed from the original scientific question. Work aimed at understanding how a microscopic organism responds to light ultimately helped create a technique capable of probing the workings of complex nervous systems.
The 2026 Nobel recognition puts that scientific journey in focus: from light sensing in a tiny alga, to genetically encoded molecular switches, and finally to a technology that has reshaped how scientists investigate the living brain.
